<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1409">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142813</url>
  </required_header>
  <id_info>
    <org_study_id>Sepsis_001</org_study_id>
    <nct_id>NCT05142813</nct_id>
  </id_info>
  <brief_title>A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children</brief_title>
  <official_title>A Cohort Study to Evaluate Biomarkers as Indicator for the Infectious Source of Sepsis Through a Blood Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>mProbe Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Second Afliated Hospital of Southern University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>mProbe Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A case-control cohort study to develop and validate the performance of a whole blood gene&#xD;
      expression test to distinguish sepsis infection from uninfected systemic inflammatory&#xD;
      response syndrome cases in symptomatic adults and children without comorbidities.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective, non-interventional study is to develop and validate a blood&#xD;
      gene expression test for diagnosing the cause of sepsis in adults and children with symptoms&#xD;
      of infection.&#xD;
&#xD;
      Sepsis affects 31.5 million people globally leading to 5.3 million deaths each year. Sepsis&#xD;
      is particularly harmful to immunodeficient patients undergoing cancer therapy with 3.7&#xD;
      percent to 6.4 percent of cancer patients diagnosed with sepsis in the US in their first year&#xD;
      after cancer diagnosis. Current tests to diagnose the infectious cause of sepsis rely on&#xD;
      blood cultures which takes 24-48 hours to complete; leading to delays in early treatment&#xD;
      critical to reduce the risk of developing sepsis shock and possibly death. In addition,&#xD;
      around 50 percent of severe sepsis cases are culture negative, confounded acute infections&#xD;
      not detected in the blood, by viral infection or uninfected patients exhibiting systemic&#xD;
      inflammatory response syndrome (SIRS). Since sepsis often progresses to sepsis shock within&#xD;
      72 hours, suspected sepsis cases are usually immediately treated with antibiotics until&#xD;
      results from testing distinguish the cause of symptoms. This leads to the over-use of&#xD;
      antibiotics and delays appropriate treatment for those without bacterial infection or&#xD;
      un-infected SIRS.&#xD;
&#xD;
      A quick and accurate diagnostic blood test may enable early discrimination of the cause of&#xD;
      sepsis resulting in faster more appropriate treatments and reduced sepsis complications and&#xD;
      death.&#xD;
&#xD;
      The study will collect blood samples from participants presenting symptoms of acute&#xD;
      infection, without co-morbidities and follow symptom severity and mortality for 28 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of underlying cause of sepsis infection</measure>
    <time_frame>1 month</time_frame>
    <description>The sensitivity and specificity of the assay in differentiating bacterial from viral infection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of underlying cause of acute infection symptoms</measure>
    <time_frame>1 month</time_frame>
    <description>The sensitivity and specificity of the assay in differentiating infectious and non-infectious disease.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Infections</condition>
  <condition>Sepsis</condition>
  <condition>SIRS</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Diagnostic Test: Blood specimen collection</intervention_name>
    <description>Diagnostic Test: Blood specimen collection Study samples must be collected within before treatment with antibiotics or antivirals.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible participants 90 days of age and older that visit the hospital or emergency&#xD;
        department with a suspected acute infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Criteria: Inclusion Criteria:&#xD;
&#xD;
          -  Clinical suspicion of an acute infectious disease&#xD;
&#xD;
          -  Presence of at least ONE of the following:&#xD;
&#xD;
               1. Temperature ≥ 38°C or Temperature ≤ 36°C&#xD;
&#xD;
               2. Heart rate &gt; 90 bpm&#xD;
&#xD;
               3. Respiratory rate &gt; 20/min&#xD;
&#xD;
               4. Self reported fever/chills&#xD;
&#xD;
          -  Symptom duration ≤ 7 days&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Received antibiotics or antivirals in the past 2 weeks.&#xD;
&#xD;
          -  Previous infection in previous 2 weeks&#xD;
&#xD;
          -  Primary or secondary immunodeficiency&#xD;
&#xD;
          -  Proven or suspected HIV, hepatitis B or hepatitis C infection&#xD;
&#xD;
          -  Current immune-suppressive or immune-modulating treatment&#xD;
&#xD;
          -  Active hematological malignancy&#xD;
&#xD;
          -  Other illnesses that affect life expectancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>90 Days</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jia Huang</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Afliated Hospital of Southern University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James Schilling</last_name>
    <phone>650479198</phone>
    <email>admin@mprobe.com</email>
  </overall_contact>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>mProbe Inc.</investigator_affiliation>
    <investigator_full_name>Jia Huang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Acute infection</keyword>
  <keyword>Fever without source</keyword>
  <keyword>Viral infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

